Filing Details

Accession Number:
0001562180-21-000358
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-15 19:03:09
Reporting Period:
2021-01-13
Accepted Time:
2021-01-15 19:03:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636422 Health Catalyst Inc. HCAT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494174 H. Daniel Orenstein C/O Health Catalyst, Inc.
3165 Millrock Drive, #400
Salt Lake City UT 84121
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-13 10,000 $10.34 68,046 No 4 M Direct
Common Stock Disposition 2021-01-13 10,000 $47.18 58,046 No 4 S Direct
Common Stock Acquisiton 2021-01-15 3,500 $10.34 61,546 No 4 M Direct
Common Stock Disposition 2021-01-15 3,500 $47.98 58,046 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-01-13 10,000 $0.00 10,000 $10.34
Common Stock Stock Option (Right to Buy) Disposition 2021-01-15 3,500 $0.00 3,500 $10.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,000 2026-02-10 No 4 M Direct
146,500 2026-02-10 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2020, in accordance with Rule 10b5-1.
  2. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.01 to $47.51, inclusive.
  3. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $47.74 to $48.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
  4. 25% of the shares vested on December 31, 2016 and the remaining 75% vested in 36 equal monthly installments thereafter until the option was vested in full on Dec. 31, 2019.